URB597

ID: Reference5002

C₂₀H₂₂N₂O₃

3'-Carbamoyl-3-biphenylyl cyclohexylcarbamate; BR-40097; FAAH Inhibitor II; KDS-4103; [3'-(Aminocarbonyl)(1,1'-biphenyl)-3-yl]-cyclohexylcarbamate ; [3-(3-Carbamoylphenyl)phenyl] N-cyclohexylcarbamate; N-Cyclohexylcarbamic acid [3-(3-carbamoylphenyl)phenyl] ester

3-Ethyl 5-methyl 2-[4-(4-fluorobenzyl)-1,4-diazepan-1-yl]-6-methylpyridine-3,5-dicarboxylate

ID: Reference5007

C₂₃H₂₈FN₃O₄

3-Ethyl 5-methyl 2-[4-(4-fluorobenzyl)-1,4-diazepan-1-yl]-6-methyl-3,5-pyridinedicarboxylate; 3,5-Pyridinedicarboxylic acid, 2-{4-[(4-fluorophenyl)methyl]hexahydro-1H-1,4-diazepin-1-yl}-6-methyl-, 3-ethyl 5-methyl ester ; 3-Ethyl 5-methyl 2-{4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl}-6-methylpyridine-3,5-dicarboxylate

5-[3-(1H-Imidazol-1-yl)propyl]-1,3,5-triazinane-2-thione

ID: Reference5021

C₉H₁₅N₅S

5-[3-(1H-Imidazol-1-yl)propyl]-1,3,5-triazinane-2-thione; 5-(3-Imidazol-1-yl-propyl)-[1,3,5]triazinane-2-thione; 1,3,5-Triazine-2(1H)-thione, tetrahydro-5-[3-(1H-imidazol-1-yl)propyl]-

3-{[(Cyanoimino)(methylthio)methyl]amino}-2-oxoazepane

ID: Reference5042

C₉H₁₄N₄OS

Methyl N-cyano-N'-(2-oxo-3-azepanyl)carbamimidothioate; Carbamimidothioic acid, N-cyano-N'-(hexahydro-2-oxo-1H-azepin-3-yl), methyl ester

Dexanabinol

ID: Reference5065

C₂₅H₃₈O₃

(6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyl-2-octanyl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol; HU-211; Sinnabidiol; (6aS,10aS)-3-(1,1-Dimethylheptyl)-9-(hydroxymethyl)-6,6-dimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol ; (6aS,10aS)-3-(1,1-Dimethyl-heptyl)-9-hydroxymethyl-6,6-dimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol ; (6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol ; (6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol

Salvinorin B

ID: Reference5073

C₂₁H₂₆O₇

Methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-2-(3-furyl)-9-hydroxy-6a,10b-dimethyl-4,10-dioxododecahydro-2H-benzo[f]isochromene-7-carboxylate; Divinorin B; 2H-Naphtho[2,1-c]pyran-7-carboxylic acid, 2-(3-furanyl)dodecahydro-9-hydroxy-6a,10b-dimethyl-4,10-dioxo-, methyl ester, (2S,4aR,6aR,7R,9S,10aS,10bR)-; (2S,4aR,6aR,7R,9S,10aS,10bR)-2-(3-Furanyl)dodecahydro-9-hydroxy-6a,10b-dimethyl-4,10-dioxo-methyl ester-2H-naphtho[2,1-c]pyran-7-carboxylic acid

Lagochilin

ID: Reference5087

C₂₀H₃₆O₅

(2R,2'R,4a'S,5S,5'R,6'S,8a'S)-5-(2-Hydroxyethyl)-5,5'-bis(hydroxymethyl)-2',5',8a'-trimethyldecahydro-2'H,3H-spiro[furan-2,1'-naphthalen]-6'-ol; Lagochiline; (1R,2S,4aS,5R,5'S,6R,8aS)-5'-(2-Hydroxyethyl)-1,5'-bis(hydroxymethyl)-1,4a,6-trimethylspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2'-oxolane]-2-ol; Spiro[furan-2(3H),1'(2'H)-naphthalene]-5,5'-dimethanol, decahydro-6'-hydroxy-5-(2-hydroxyethyl)-2',5',8'a-trimethyl-, (2R,2'R,4'aS,5S,5'R,6'S,8'aS)-

Boldenone cypionate

ID: Reference5105

C₂₇H₃₈O₃

(17β)-3-Oxoandrosta-1,4-dien-17-yl 3-cyclopentylpropanoate; Cyclopentanepropanoic acid, (17β)-3-oxoandrosta-1,4-dien-17-yl ester; [(8R,9S,10R,13S,14S,17S)-10,13-Dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate

JWH-133

ID: Reference5111

C₂₂H₃₂O

(6aR,10aR)-6,6,9-Trimethyl-3-(2-methyl-2-pentanyl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromene; JWH 133 ; (6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromene; (6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene; 1,1-Dimethylbutyl-1-deoxy-δ(9)-THC ; 3-(1,1-Dimethylbutyl)-1-deoxy-δ8-tetrahydrocannabinol; 3-(1,1-Dimethylbutyl)-1-deoxy-δ8-THC

Propylhexedrine

ID: Reference5171

C₁₀H₂₁N

1-Cyclohexyl-N-methyl-2-propanamine; Benzedrex; CHP-Depot; Dristan; Dristan inhaler; Hexahydrodesoxyephedrine; Hydromethamphetamine

Salinomycin

ID: Reference5177

C₄₂H₇₀O₁₁

(2R)-2-{(2R,5S,6R)-6-[(2S,3S,4S,6R)-6-{(2S,5S,7R,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-Ethyl-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5.3]pentadec-13-en-9-yl}-3-hydroxy-4-methyl-5-oxo-2-octanyl]-5-methyltetrahydro-2H-pyran-2-yl}butanoic acid; Bio-cox; Coxistac; Procoxacin; 2H-Pyran-2-acetic acid, α-ethyl-6-((1S,2S,3S,5R)-5-{(2S,5S,7R,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5.3]pentadec-13-en-9-yl}-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-5-methyl-, (αR,2R,5S,6R)-

2-[6-(1,3-Dioxo-2,3,3a,4,7,7a-hexahydro-1H-isoindol-2-yl)-2-pyridyl]-2,3,3a,4,7,7a-hexahydro-1H-isoindole-1,3-dione

ID: Reference5181

C₂₁H₁₉N₃O₄

2,2'-(2,6-Pyridinediyl)bis(3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione); 1H-Isoindole-1,3(2H)-dione], 2,2'-(2,6-pyridinediyl)bis[3a,4,7,7a-tetrahydro-